| |
| Dr. Shrinivas D. Joshi, M. Pharm., Ph.D |
|
Professor and Head, Department of Pharmaceutical Chemistry
Contact information : SET’s College of Pharmacy, S. R. Nagar,
Dharwad-580002. |
Phones : Mob. No- 09986151953; Off: +91-836-2448540;
Fax: +91-836-2467190 |
| E-mail : shrinivasdj@rediffmail.com |
|
| |
Dr. S. D. Joshi completed his B. Pharm from Karnatak University, Dharwad, M. Pharm from Rajiv Gandhi University of Health Sciences, Bangalore and Ph.D from Kuvempu University, Shimoga. Presently, Dr. Joshi is a Professor and Head, Department of Pharmaceutical Chemistry, having 17 years of teaching and 13 years of research experience. His areas of expertise include: drug design and synthesis of new chemical entities for various therapeutic effects. He is working on QSAR, Molecular Modeling and Ligand enzyme binding interaction studies using molecular modeling software i.e. Sybyl-X 2.0 (Tripos USA) in addition to synthesis and pharmacological screening of potential therapeutic agents. |
| |
| Representative Publications: |
1 |
Chemical synthesis and in silico molecular modeling of novel pyrrolyl benzohydrazide derivatives: their biological evaluation against enoyl ACP reductase (InhA) and Mycobacterium tuberculosis. Shrinivas D. Joshi, Uttam A. More, Sheshagiri R. Dixit, Sunil V. Balmi, Basavaraj G. Kulkarni, Geeta Ullagaddi, Christian Lherbet, Tejraj M. Aminabhavi
Bioorganic Chemistry, 75, 2017, 181-200 (I.F. 3.213), (Elsevier). |
2 |
3D-QSAR and molecular docking studies of pyrazole derivatives as inhibitors of enoyl acyl carrier protein reductase fromMycobacterium tuberculosis.
Shrinivas D. Joshi, Sheshagiri R. Dixit, K. V. S. N. Raju, Ramanuj Narayan, Tejraj M. Aminabhavi, V. H. Kulkarni.
Letters in Drug Design and Discovery, 2017, 14(4), 414-433 (I.F. 1.10), (Bentham). |
3 |
Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes.
Shrinivas D. Joshi, Devendra Kumar, Sheshagiri R. Dixit, Nageshwar Tigadi, Uttam A. More, Christian Lherbet, Tejraj M. Aminabhavi, Kap Seung Yang
European Journal of Medicinal Chemistry, (I.F. 3.499), (Elsevier) 2016, 121, 21-39.
|
4 |
Design and development of pyrrole carbaldehyde: An effective pharmacophore for enoyl-ACP reductase.
Shrinivas D. Joshi, Devendra kumar, Uttam A. More, Kap Seung Yang, Tejraj M. Aminabhavi.
Medicinal Chemistry Research 2016, 25:672-689, (I.F. 1.612), Springer.
|
5 |
Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties
Shrinivas D. Joshi, Sheshagiri R. Dixit, Kirankumar M. N, Tejraj M. Aminabhavi, K. V. S. N. Raju, Ramanuj Narayan, Christian Lherbet, Kap Seung Yang.
European Journal of Medicinal Chemistry, 107, 2016, 133-152 (I.F. 3.499), (Elsevier), (I.F. 3.499) (One among the most downloaded European Journal of Medicinal Chemistry articles in 2016)
|
6 |
Discovery of target based novel pyrrolyl phenoxy derivatives as antimycobacterial agents: an in silico approach.
Uttam A. More, Shrinivas D. Joshi, Tejraj M. Aminabhavi, Venkatrao H. Kulkarni, Aravind M. Badiger, Christian Lherbet.
European Journal of Medicinal Chemistry, 94, 2015, 317-339 (I.F. 3.499), (Elsevier).
|
7 |
Design, synthesis of quinolinyl Schiff bases and azetidinones as antimycobacterial agents.
Shrinivas D. Joshi, Uttam A More, Deepak Parkale, Tejraj. M. Aminabhavi, Andanappa K. Gadad, Mallikarjuna N. Nadagouda, Rahul Jawarkar.
Medicinal Chemistry Research 2015, 24, 11, 3892-3911 (I.F. 1.612), (Springer), [Citation: 2]
|
8 |
Synthesis, evaluation and in silico molecular modeling of pyrroyl-1,3,4-thiadiazole inhibitors of InhA.
Shrinivas D. Joshi, Uttam A. More, Deepshikha Koli, Manoj S. Kulkarni, Mallikarjuna N. Nadagouda, Tejraj M. Aminabhavi.
Bioorganic Chemistry, 2015, 59, 151-167. (I.F. 2.141), (Elsevier).
|
9 |
Enoyl ACP reductase as effective target for the synthesized novel antitubercular drugs: A-state-of- the-art.
Shrinivas D. Joshi, Sheshagiri R. Dixit, Uttam A. More, Tejraj M. Aminabhavi, Venkatrao H. Kulkarni, Andanappa K. Gadad
Mini Reviews in Medicinal Chemistry, 2014, 14, 678-693, (I.F. 3.186), (Bentham).
|
10 |
3D-QSAR and molecular docking studies of 1,3,4-oxadiazoles containing substituted phenoxy fragment as inhibitors of enoyl acyl carrier protein reductase from Escherichia coli.
Shrinivas D. Joshi, Sheshagiri R. Dixit, Uttam A. More, K. V. S. N. Raju, Ramanuj Narayan, Tejraj M. Aminabhavi, V. H. Kulkarni
Medicinal Chemistry Research, 2014, 23, 4542-4558. (I.F. 1.612), (Springer).
|
|
|
|
